Empowering Immigrants in the Greater Boston Area to Connect to HBV Care

Status Active, not recruiting

Clinical Trial Summary

This Study will attempt to provide information / linkage to HBV care for persons at risk in the Greater Boston area.

Clinical Trial Description

Specific Aims

1. Provide HBV education at community sites where immigrants at risk for HBV could be informed of the risks related to HBV, in a culturally and linguistically sensitive manner.

1. Chelsea, Charlestown, and Revere MGH Community Health Centers: posters, pamphlets, and telephone line to provide HBV education

2. Senegalese Community Center: community meeting, posters, and pamphlets

3. African Students' Association, Suffolk University: community meeting, posters, and pamphlets

4. Revere Cambodian Community Centers: community meeting, posters, and pamphlets

2. Provide at-risk persons with the tools to develop an HBV diagnosis plan with his / her provider.

1. Provide counseling on the significance of different testing results prior to testing

2. Connect to testing, and appropriate post-test follow-up appointments

3. Provide an education hub for patients and providers to return to with questions regarding: test interpretation, available treatments for those who test positive, and screening for hepatocellular carcinoma in those who are infected.

1. Provide copy of an easy to understand US HBV treatment algorithm in native languages

2. Provide information related to genotype-specific risks for HCC (increased with GT C). ;

Study Design

Related Conditions & MeSH terms

Hepatitis

Clinical Trial Details

NCT number	NCT02342821
Study type	Observational
Source	Massachusetts General Hospital
Contact
Status	Active, not recruiting
Phase	N/A
Start date	February 2015
Completion date	June 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05738681` - Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial	Phase 2/Phase 3
Recruiting	`NCT05989958` - The Safety and Tolerability Study of HepaCure in Chinese Subjects With Acute-On-Chronic Liver Failure	Phase 1
Not yet recruiting	`NCT06395129` - Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
Terminated	`NCT01443923` - Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV	Phase 4
Completed	`NCT00679692` - Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease	N/A
Completed	`NCT00300209` - Manhattan HIV/Hepatology Brain Bank	N/A
Recruiting	`NCT05563961` - A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers	N/A
Recruiting	`NCT05635266` - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed	`NCT00160407` - Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)	Phase 4
Recruiting	`NCT03692897` - An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
Completed	`NCT03509688` - The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial	N/A
Recruiting	`NCT02275195` - Immune Cell Dysfunction in Severe Alcoholic Hepatitis
Completed	`NCT01740089` - Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C	Phase 2/Phase 3
Completed	`NCT00987337` - Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects	Phase 2
Completed	`NCT00929786` - Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity	N/A
Completed	`NCT00564642` - Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity	N/A
Completed	`NCT00080236` - Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation	Phase 2
Recruiting	`NCT05719480` - A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer
Suspended	`NCT04306939` - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Completed	`NCT03482388` - Crowdsourcing to Promote HBV and HCV Testing in China	N/A